{
  "trial_id": "NCT03556384",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "pathologically confirmed SDH-mutant/deficient GIST",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "recovered from acute toxic effects of all prior chemotherapy, immunotherapy, or radiotherapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ECOG Performance Status 0-2",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "adequate hematologic, hepatic and renal function",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "measurable or evaluable disease as per RECIST v1.1",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "life expectancy of >12 weeks",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "major surgery within 4 weeks of initiation of study medication",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "concurrent anti-neoplastic therapy at the start of study treatment",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "brain metastases",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "severe or uncontrolled systemic diseases",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and is currently experiencing progressive lower extremity weakness and urinary retention. The patient's medical condition makes it undesirable for them to participate in this trial.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT03556384",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}